The Health Ministry has launched investigations into the rising misuse of Ozempic, which is a diabetes drug, that Kenyans are instead using for weight loss.
Health Principal Secretary Mary Muthoni confirmed the probe on Thursday, noting that the Pharmacy and Poisons Board (PPB) had taken up the matter following growing concerns from health professionals.
Ozempic, originally prescribed to manage Type 2 diabetes, has gained popularity for its weight-loss effects, prompting fears of shortages and potential health risks for patients who genuinely need it for diabetes management.
According to Muthoni, the ministry had noted with concern the growing number of Kenyans misusing the substance contrary to the health requirements.
